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Abstract
Background: Post infarction ventricular septal defect (VSD) is an uncommon but life threatening complication of
acute myocardial infarction.
Case presentation: A 62-year-old woman was admitted with acute myocardial infarction (AMI). However, the day
after angioplasty and stenting, Transthoracic echocardiography (TTE) showed post infarction VSD. We decided to
insert an extracorporeal membrane oxygenation (ECMO) device for stabilization purposes before surgical repair.
After 4 days from the implantation, we performed surgical repair successfully.
Conclusions: When optimal medical treatment fails to stabilize a patient in cardiogenic shock, peripheral ECMO
could be used as a bridge to definitive surgical therapy.
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Background
Rupture of the ventricular septum after acute myocar-
dial infarction (AMI) is a serious complication. In the
pre-thrombolytic era, its incidence was 1–2 % but the
use of thrombolytic agents reduced it to 0.2 % [1, 2].
The mortality rate with only medical treatment
reaches 90–95 %, but the rate varies from 19 to 60 %
with surgical intervention [1].
Despite optimal medical treatment, when ventricular
septal defect (VSD) related cardiogenic shock causes
rapid deterioration, surgical repair is the only definitive
treatment. However, early surgical repair is difficult and
complicated due to the presence of friable, infarcted,
necrotic tissue.
To defer surgery in patients with cardiogenic shock,
peripheral ECMO could be used as a temporary bridge
to definitive surgical repair after post AMI VSD.
Case presentation
A 62-year-old woman with a history of hypertension
was admitted with complaints of chest pain and
shortness of breath of 3 days duration. Her heart rate
was 89 bpm, blood pressure 105/70 mmHg, and
temperature 36.5 °C. Chest X-ray revealed cardiomeg-
aly and pulmonary edema. On admission, blood tests
revealed Hb 10.9 g/dl, troponin I 5.26, CK-MB 4 ng/
ml. Arterial blood gas revealed pH 7.32, pCO 2 21.6,
pO 2 80.2 mmHg, bicarbonate 11 mmol/l and SaO 2
92.8 % on room air. Electrocardiography (ECG)
showed ST-segment elevation and Q waves in leads
V1-4 and coronary catheterization revealed total prox-
imal occlusion of the anterior interventricular branch
of the left coronary artery. Angioplasty and stent im-
plantation were performed, and chest pain, shortness
of breath, and general malaise disappeared after the
procedure. However, the day after angioplasty and
stenting, the patient suddenly experienced fatigue,
dyspnea, and tachycardia. At this time, her blood
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On physical examination, auscultation revealed a 3/6
pan-systolic murmur in the left parasternal area.
Transthoracic echocardiography (TTE) with Doppler
showed an akinetic area in the apex, an ejection frac-
tion of 43 %, and confirmed 15 mm and 8 mm VSDs
in the apicoanterior and mid anterior ventricular
septum (Fig. 1). Tricuspid regurgitation was mild with
moderate pulmonary arterial hypertension with systolic
pulmonary artery pressure of 50 mmHg. The total pul-
monary to total systemic blood flow ratio (Qp/Qs) of
VSD was 5.7.
Symptoms of congestive heart failure progressed due
to low cardiac output, and the patient was transferred to
the intensive care unit to treat the heart failure and to
prevent progression of cardiogenic shock. After her in-
tubation, we administered maximum dose of inotropics
and vasopressors. Despite optimal medical treatment,
pulmonary hypertension and pulmonary congestion
gradually increased, and urine output decreased. We de-
cided to insert an extracorporeal membrane oxygenation
(ECMO) device for stabilization purposes before surgical
repair, and ECMO support was emergently initiated via
a left femoral artery and right femoral vein. Arterial
and venous cannulations were performed percutan-
eously, and distal limb perfusion was achieved with an
introducer sheath (7 Fr). Stabilization of the patient was
immediate and her clinical status improved. Accordingly,
surgical VSDs repair was postponed. After 4 days from
the implantation, signs of left leg ischemia developed;
hence, we decided to perform surgical repair. On the same
day, closure of the VSDs was performed using two patches
of bovine pericardium by bilateral ventriculotomy. Using
interrupted mattress suture, one patch was placed on the
left ventricular (LV) side and the other on the RV side of
the VSD. Lastly, both ventriculotomies were closed using
Teflon strips to buttress the suture lines. Cardiopulmo-
nary Bypass (CPB) and aortic cross clamp (ACC) times
were 219 and 194 min, respectively. Immediately following
the surgery, the patient was stable and had a good urine
output. Her postoperative course was uneventful. On
the third postoperative day, the patient was extubated
and transferred to the general ward on the fourth
postoperative day.
The TTE prior to discharge showed a residual 6 mm
VSD in the mid anterior ventricular septum, and at this
time, the total pulmonary to total systemic blood flow
ratio (Qp/Qs) of the residual VSD was 1.1. However, the
patient’s hemodynamics were stable. The patient was
discharged on the fourteenth postoperative day without
symptoms of heart failure.
Fig. 1 Preoperative echocardiographic findings. a TTE in four chamber view showing a 15 mm VSD in the apicoanterior ventricular septum with
left to right shunt. b Color flow Doppler image showing the 8 mm VSD in the mid anterior ventricular septum
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After thirty months postoperatively, the patient remained
in good condition clinically. The patient’s blood pressure
was well controlled and renal function was normal. Follow-
up TTE revealed no significant changes.
Discussion
Post AMI VSD is a serious clinical problem with a high
mortality rate; thus, the management of patients with
post AMI VSD is challenging. IABP (intra-aortic balloon
pump) provides afterload reduction for the left ventricle,
increase in diastolic perfusion of coronary arteries, and
decrease in left to right shunting. However, in patients
presenting with cardiogenic shock following AMI, the
use of a percutaneously placed LVAD (left ventricular as-
sist device) is more feasible, safe, and provides superior
hemodynamic support than the standard treatment
using IABP [3]. In our hospital, for the patients with
post-MI VSD with refractory cardiogenic shock, periph-
eral VA ECMO is the quickest, the easiest, and the least
invasive ventricular support device.
When medical treatment is applied alone, mortality
reaches 90–95 %, whereas for surgical repair mortality
varies from 19 to 60 % [1]. Thus, surgical repair of post
infarction VSD is the definitive treatment of choice [4].
Percutaneous closure using a septal occluder device can
be the primary treatment for anatomically suitable pa-
tients. Unfortunately, we did not have any experiences
with percutaneous interventions nor closure devices.
A recent publication released by the Society of Thoracic
Surgeons National Database showed that patient mortality
is significantly dependent on the timing of surgery. Pa-
tients that underwent surgery within 7 days of symptoms
onset were found to have a 54 % mortality rate, but when
surgical repair was delayed for more than 7 days after
VSD post AMI, the mortality rate fell to 18 % [5]. How-
ever, these rates may be unduly biased, because early
surgery is usually performed in the patients with marked
hemodynamic instability and circulatory compromise.
After AMI, time is needed for the regeneration of heart
muscle tissues in the necrotic area [6].
During the early phase of post AMI, infarcted myocar-
dium is weak and friable, and this may prevent appropri-
ate stitching of patch materials around a septal rupture.
Consequently, stitches may be pulled out of septal tissue,
which increases the risk of tearing and recurrent septal
defects. Accordingly, the more chronic VSD is, the easier
it is to repair because the septum is well scarred and a
patch can be securely sutured.
However, it should be borne in mind that when pa-
tients with VSD related cardiogenic shock deteriorate
rapidly, surgical repair is the only definitive treatment.
We would recommend implementing resuscitative
measures initially, especially in patients with cardio-
genic shock.
Conclusions
In conclusion, veno-arterial (VA) ECMO may be an
effective means of providing temporary assistance in
patients with post AMI VSD related to cardiogenic
shock. We suggest when optimal medical treatment fails
to stabilize a patient in cardiogenic shock, peripheral VA
ECMO could be used as a temporary bridge to definitive
surgical repair.
Further studies are needed to assess the effectiveness
of ECMO in this patient population.
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